IACT Health’s CIO, Christine Senn, Ph.D., is one of the 1st candidates to be awarded the inaugural credential of ACRP Certified Professional (ACRP-CP). This makes Dr. Senn one of only two in the entire (international) organization who is triple-certified by ACRP. Not only did she meet their rigorous eligibility requirements, she also passed the standardized ACRP-CP Certification Exam that requires a person to have a proficiency in a number of core knowledge areas, spanning 125 questions, covering a wide range of ICH Guidelines. This designation “formally recognizes a professional who has met the professional standards set forth by the Academy of Clinical Research Professionals”. At IACT Health, Dr. Senn is responsible for transitioning research-naïve group practices into accomplished, multi-trial sites. She serves as QA reviewer, trainer, and logistics coordinator during setup. Dr. Senn holds her Ph.D. in Psychology and has a Masters degrees in both Clinical Psychology and Advertising and Public Relations.
IACT Health’s Chief Information Officer, Dr. Christine Senn, pH.D., CCRC, CPI and Katrina Quidley, Regulatory Manager, have both been awarded the inaugural credential of ACRP Certified Professional (ACRP-CP). As two of the first candidates ever to receive this designation, not only did they meet the rigorous eligibility requirements, they also passed the standardized ACRP-CP Certification Exam.
This designation “formally recognizes a professional who has met the professional standards set forth by the Academy of Clinical Research Professionals”.
IACT Health is proud to announce the success of a clinical trial in partnership with Sunovion Pharmaceuticals. Due to the success of IACT’s clinical trial, a new long-acting nebulizer inhaler, Lonhala Magnair, has been approved for long-term maintenance treatment in patients with COPD, including bronchitis and emphysema.
This approval provides physicians and patients with the first nebulized LAMA as an additional therapeutic option for the management of COPD.
IACT Health has just become the latest network of clinical research sites to take advantage of Devana Solutions® IGNITE FOR SITES advanced central data analytics technology for clinical trial sites. The decision puts the 12-year old network of sites in good company as many of the industry leading sites and networks that have adopted Devana’s IGNITE can report not only their historical performance metrics but can also capture and deliver their site timing and performance metrics to Sponsors and CROs in real time. This will enable IACT Health and other leading trial site networks on IGNITE FOR SITES to align therapeutically and operationally with those Sponsors or CROs seeking to conduct clinical trials where IACT’s performance is second to none.
“Ultimately, this alignment between the top trial sites, Sponsors and CROs through Devana Solutions technology is at the heart of our mission,” explains Barry Lake, Devana’s CEO. “The greatest impact we can make on lowering drug development costs is through cutting clinical trial cycle times and our platform aims to do just that.”
“Prior to implementing Devana Solutions IGNITE FOR SITES system, we were struggling to effectively track our site metrics through a combination of our CTMS (Clinical Trial Management Software) and a myriad of Excel Spreadsheets,” states Felicia Irvin, Vice President of Sales and Marketing at IACT Health. “Now, the Devana technology has everything in one centralized place and we can quickly and efficiently access our site’s performance metrics to analyze and complete a Sponsor Feasibility questionnaire in minutes.”
IACT Health is an integrated network of 10 strong investigative sites with a wealth of clinical trial experience in over 25 therapies with particular strength in Pulmonary Disease, Infectious Disease and Dermatology. Led by Dr. Jeff Kingsley, a clinical trial industry leader, and headquartered in Columbus, Georgia, IACT Health has completed well over 300 studies. Over 100 Physician Investigators have conducted studies with the IACT Health site network and the group employs 11 full-time Clinical Research Coordinators (CRC). IACT has won awards ranging from “Top 10 Best Places to Work in Georgia” according to Georgia Trend Magazine (2009), the “Psychologically Healthy Workplace Award” from the Georgia Psychological Association (2012) and more recently, the “Rockstar Award” as bestowed by the Georgia Department of Economic Development (2016).
Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is key in the selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers two platforms, IGNITE FOR SITES and MATCH PERFORMANCE, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. To learn more visit http://devanasolutions.com.
Columbus Regional Research Institute and IACT Health are testing an investigational drug on Crohn’s disease to see if it can reduce the symptoms of flare-ups. If you are 18-75 yrs old and have not had previous luck with prescribed medications, and are currently having a flare-up, you may be eligible for the trial.
IACT Health is a Columbus based regional clinical research site network uniquely staffed entirely by specialists. From locations throughout the Southeast, IACT Health conducts studies for the pharmaceutical, biotech and medical device industries. Columbus Regional Research Institute is a partnership between IACT Health and Columbus Regional Health to facilitate clinical research opportunities for patients throughout the region.
Please visit www.iact-health-staging.ycjrvwt5-liquidwebsites.com/studies to learn more.